LGC appoints Vivid Sehgal as Chief Financial Officer

News - Replaces Simon Parsons, who will leave LGC after 11 years of service

17 January 2022

Ampersand-backed Alliance Pharma to acquire LGC’s Drug Development Solutions Business (“DDS”) and welcomes KKR as joint shareholder

News - DDS is a European provider of Bioanalytical and Analytical and Materials Science Solutions to pharma, biopharma, consumer healthcare and consumer products clients, located in Cambridge and Sandwich, UK

17 May 2022

LGC’s new state-of-the-art site in Oxford will deliver critical diagnostics solutions and research

News - Facility will serve as home of The Native Antigen Company and an advanced workflow applications laboratory for LGC Biosearch Technologies

16 September 2022